Related Experiment Video
Updated: Mar 30, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.4K
Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas
Min Ji Jeon1, Won Gu Kim1, Yun Mi Choi1
11 Department of Internal Medicine, University of Ulsan College of Medicine , Seoul, Korea.
Thyroid : Official Journal of the American Thyroid Association
|November 14, 2015
Summary
Papillary thyroid microcarcinomas (PTMCs) rarely metastasize distantly, but when they do, it can be fatal. Meticulous examination of lymph nodes for extranodal extension and aggressive subtypes helps assess this risk.
Area of Science:
- Oncology
- Pathology
Background:
- Papillary thyroid microcarcinomas (PTMCs) incidence is rising, often treated conservatively.
- PTMCs can present with distant metastasis, necessitating risk assessment.
- This study evaluates PTMC clinicopathological features and distant metastasis risk factors.
Purpose of the Study:
- To identify clinicopathological features associated with distant metastasis in PTMC patients.
- To evaluate risk factors for distant metastasis in PTMC.
Main Methods:
- Retrospective review of 8808 PTMC patients (1999-2012).
- Identified 12 patients with distant metastasis.
- Compared with 41 PTMC patients without distant metastasis (control group).
Main Results:
- All 12 patients with distant metastasis had tumors >0.5 cm and cervical lymph node metastasis.
- Extranodal extension and aggressive metastatic lymph node subtypes were significantly associated with distant metastasis.
- Disease-specific mortality linked to older age, large metastatic LNs with extranodal extension, and aggressive subtypes.
Conclusions:
- Distant metastasis from PTMC is rare but can be fatal.
- Pathologic examination of metastatic lymph nodes for extranodal extension and subtype is crucial for risk assessment.
- Conservative management of PTMC should consider these potential risks.
Related Concept Videos
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K

